首页> 美国卫生研究院文献>Assay and Drug Development Technologies >A High-Throughput Time-Resolved Fluorescence Energy Transfer Assay to Screen for Modulators of RGS7/Gβ5/R7BP Complex
【2h】

A High-Throughput Time-Resolved Fluorescence Energy Transfer Assay to Screen for Modulators of RGS7/Gβ5/R7BP Complex

机译:用于筛选RGS7 /Gβ5/ R7BP复合物调节剂的高通量时间分辨荧光能量转移分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

G protein-coupled receptors (GPCRs) are excellent drug targets exploited by majority of the Food and Drug Administration-approved medications, but when modulated, are often accompanied by significant adverse effects. Targeting of other elements in GPCR pathways for improved safety and efficacy is thus an unmet need. The strength of GPCR signaling is tightly regulated by regulators of G protein signaling (RGS) proteins, making them attractive drug targets. We focused on a prominent RGS complex in the brain consisting of RGS7 and its binding partners Gβ5 and R7BP. These complexes play critical roles in regulating multiple GPCRs and essential physiological processes, yet no small molecule modulators are currently available to modify its function. In this study, we report a novel high-throughput approach to screen for small molecule modulators of the intramolecular transitions in the RGS7/Gβ5/R7BP complex known to be involved in its allosteric regulation. We developed a time-resolved fluorescence energy transfer-based in vitro assay that utilizes full-length recombinant proteins and shows consistency, excellent assay statistics, and high level of sensitivity. We demonstrated the potential of this approach by screening two compound libraries (LOPAC 1280 and MicroSource Spectrum). This study confirms the feasibility of the chosen strategy for identifying small molecule modulators of RGS7/Gβ5/R7BP complex for impacting signaling downstream of the GPCRs.
机译:G蛋白偶联受体(GPCR)是食品和药物管理局批准的大多数药物所利用的优良药物靶标,但是如果进行调制,通常会伴随着明显的不良反应。因此,针对GPCR途径中其他元素的靶向性以提高安全性和功效是未满足的需求。 GPCR信号的强度受到G蛋白信号(RGS)蛋白调节剂的严格调节,使其成为有吸引力的药物靶标。我们专注于大脑中由RGS7及其结合伴侣Gβ5和R7BP组成的著名RGS复合物。这些复合物在调节多种GPCR和必需的生理过程中起着关键作用,但是目前尚无小分子调节剂可用于调节其功能。在这项研究中,我们报告了一种新颖的高通量方法,可筛选已知参与其变构调节的RGS7 /Gβ5/ R7BP复合物中分子内过渡的小分子调节剂。我们开发了一种基于时间分辨荧光能量转移的体外测定方法,该方法利用了全长重组蛋白,显示出一致性,优异的测定统计数据和高水平的灵敏度。我们通过筛选两个化合物库(LOPAC 1280和MicroSource Spectrum)证明了这种方法的潜力。该研究证实了所选择策略用于鉴定RGS7 /Gβ5/ R7BP复合物的小分子调节剂以影响GPCR下游信号的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号